Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue

Clinical and Experimental Immunology

Volumn 111, Issue 2, 1998, Pages 353-358

  Reme T ^a,b   Travaglio, A ^a   Gueydon, E ^a   Adla, L ^a   Jorgensen, C ^a   Sany, J ^c  

^a LAPEYRONIE HOSPITAL   (France)

^b INSERM   (France)

^c INSERM U291 ^*

Author keywords

Apoptosis; DNA damage; Histocytochemistry; Oncogenes; Suppressor mutation

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE EROSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANNUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SYNOVIOCYTE; SYNOVIUM; TUMOR SUPPRESSOR GENE;

EID: 0031911731     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00508.x     Document Type: Article

References (26)

1. Trabandt A, Gay RE, Gay S. Oncogene activation in rheumatoid synovium. APMIS 1992; 100:861-75.
2. Bishop JM. Molecular themes in oncogenesis. Cell 1991; 64:235-48.
3. Marshall CJ. Tumor suppressor genes. Cell 1991; 64:313-26.
4. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. New England J Med 1993; 329:1318-27.
5. Clarke AR, Purdie CA, Harrison DJ et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362:849-52.
6. Dittmer D, Pati S, Zambetti G et al. Gain of function mutations in p53. Nature Genet 1993; 4:42-46.
7. Oren M, Maltzman W, Levine AJ. Posttranslational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1981; 1:101-10.
8. Lu X, Lane DP. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 1993; 75:765-78.
9. Jonason AS, Kunala S, Price GJ et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 1996; 93:14025-9.
10. Tadini G, Cerri A, Crosti L et al. p53 and oncogene expression in psoriasis. Acta Derm Venereol 1989; 146:33-35.
11. Molès JP, Theillet C, Basset-Seguin N et al. Mutation of the tumor suppressor gene TP53 is not detected in psoriatie skin. Invest Dermatol 1993; 101:100-2.
12. Kovacs B, Patel A, Hershey JN et al. Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic-diseases. Arthritis Rheum 1997; 40:980-2.
13. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
14. Togushida J, Yamagushi T, Ritchie B et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 1992; 52:6194-9.
15. Orita M, Iwahana H, Kanazawa H et al. Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformations polymorphisms. Proc Natl Acad Sci USA 1989; 86:2766-70.
16. Cordell JF, Falini B, Erber WN et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32:219-29.
17. Mazars GR, Portier M, Zhang XG et al. Mutations of the p53 gene in human myeloma cell lines. Oncogene 1992; 7:1015-8.
18. Gaidano G, Ballerini P, Gong JZ et al. P53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88:5413-7.
19. Soussi T, Caron de Fromentel C, May P. Structural aspects of the p53 protein in relation to gene evolution. Oneogene 1990; 5:945-52.
20. Dooley S, Helitzka I, Hanselmann R et al. Constitutive expression of c-fos and c-jun, overexpression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis. Ann Rheum Dis 1996; 55:298-304.
21. Firestein GS, Nguyen K, Aupperle KR et al. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996; 149:2143-51.
22. Watanabe-Fukunaga R, Brannan CI, Copeland NG et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-7.
23. Chu JL, Drappa J, Parnassa A et al. The defect of Fas mRNA expresion in MRL-lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 1993; 178:723-30.
24. Mountz JD, Wu J, Cheng J et al. Autoimmune diseases. A problem of defective apoptosis. Arthritis Rheum 1994; 37:1415-20.
25. Nakajima T, Aono H, Hasunuma T et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995; 38:485-91.
26. Martinez-Delgado B, Robledo M, Arranz E et al. Correlation between mutations in p53 gene and protein expression in human lymphomas. Am J Hematol 1997; 55:1-8.